We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
BMY

Price
46.86
Stock movement up
+0.02 (0.04%)
Company name
Bristol-Myers Squibb Company
Exchange
(NYSE
,
Currency
USD
)
Sector
Healthcare >
Drug Manufacturers - General
Market cap
95.38B
Ent value
163.96B
Price/Sales
2.01
Price/Book
5.55
Div yield
5.29%
Div growth
7.34%
Growth years
12
FCF payout
34.81%
Trailing P/E
-
Forward P/E
7.78
PEG
-
EPS growth
5.14%
1 year return
14.38%
3 year return
-13.69%
5 year return
-3.56%
10 year return
-3.34%
Last updated: 2025-08-27

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

DIVIDENDS

Dividend yield - 5y

Loading...
Dividend yield data
Dividend per share2.48
Dividend yield5.29%
Payout frequencyQuarterly
Maximum yield6.05%
Average yield3.72%
Minimum yield2.66%
Discount to avg yield29.74%
Upside potential42.32%
Yield as % of max yield87.46%

Yield distribution (inverse percentile) - 5y

Loading...
Yield distribution data
Dividend yield5.29%
Current yield distribution5.56%
Yield at 100% (Min)2.66%
Yield at 90%2.89%
Yield at 80%3.00%
Yield at 50% (Median)3.34%
Yield at 20%4.58%
Yield at 10%4.95%
Yield at 0% (Max)6.05%

Dividend per share

Loading...
Dividend per share data
Years of growth12 years
CCC statusDividend Contender
Dividend per share2.48
Payout frequencyQuarterly
Ex-div date3 Jul 2025
EPS (TTM)-3.57
EPS (1y forward)6.02
EPS growth (5y)5.14%
EPS growth (5y forward)18.40%

Dividend growth

Loading...
Please create a free account or log in to access this chart
Dividend growth data
BMYS&P500
DGR MR3.33%-13.74%
DGR TTM3.80%6.60%
DGR 3 years-0.15%5.24%
DGR 5 years7.34%5.40%
DGR 10 years2.62%7.07%
DGR 15 years2.61%6.12%
Time since last change announced264 days
EPS growth (5y)5.14%
EPS growth (5y forward)18.40%

Payout ratio

Loading...
Please create a free account or log in to access this chart
Payout ratio data
EPS coverageFCF coverage
TTM-66.20%34.81%
Average--
Forward41.17%-

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF6.36
Price to FCF6.91
Price to EBITDA5.38
EV to EBITDA9.24

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales2.01
Price to Book5.55
EV to Sales3.46

FINANCIALS

Per share

Loading...
Per share data
Current share count2.04B
EPS (TTM)-3.57
FCF per share (TTM)6.80

Income statement

Loading...
Income statement data
Revenue (TTM)47.44B
Gross profit (TTM)33.40B
Operating income (TTM)10.31B
Net income (TTM)-7.26B
EPS (TTM)-3.57
EPS (1y forward)6.02

Margins

Loading...
Margins data
Gross margin (TTM)70.41%
Operating margin (TTM)21.74%
Profit margin (TTM)-15.30%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash7.89B
Net receivables14.89B
Total current assets28.07B
Goodwill21.75B
Intangible assets26.96B
Property, plant and equipment13.09B
Total assets93.67B
Accounts payable3.47B
Short/Current long term debt51.40B
Total current liabilities22.64B
Total liabilities76.47B
Shareholder's equity17.20B
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)15.00B
Capital expenditures (TTM)1.20B
Free cash flow (TTM)13.80B
Dividends paid (TTM)4.80B

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-42.20%
Return on Assets-7.75%
Return on Invested Capital-10.81%
Cash Return on Invested Capital20.57%

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open46.92
Daily high47.40
Daily low46.72
Daily Volume47.3M
All-time high81.13
1y analyst estimate53.00
Beta0.37
EPS (TTM)-3.57
Dividend per share2.48
Ex-div date3 Jul 2025
Next earnings date31 Oct 2025

Downside potential

Loading...
Downside potential data
BMYS&P500
Current price drop from All-time high-42.24%-3.04%
Highest price drop-76.73%-56.47%
Date of highest drop16 Oct 20089 Mar 2009
Avg drop from high-34.08%-11.04%
Avg time to new high43 days12 days
Max time to new high4176 days1805 days

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
BMY (Bristol-Myers Squibb Company) company logo
Marketcap
95.38B
Marketcap category
Large-cap
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Opdivo for various anti-cancer indications; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel to treat patients with Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of relapsed/refractory multiple myeloma; Abecma for the treatment of patients with relapsed or refractory multiple myeloma; Reblozyl to treat anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of patients with relapsed or refractory large B-cell lymphoma; Cobenfy to treat schizophrenia in adults; Krazati for the treatment of adult patients with KRASG12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC); Camzyos to treat symptomatic obstructive HCM to improve functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug to treat multiple myeloma; and Abraxane for the treatment of breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.
Employees
34100
SEC filings
CEO
Giovanni Caforio
Country
USA
City
New York
Stock type
Common stock
CCC status
Dividend Contender
Dividend Frequency
Quarterly
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...